Diabetes Mellitus Clinical Trial
Official title:
Effect of Apple Cider Vinegar in Type 2 Diabetic Patients With Poor Glycemic Control: a Randomized Controlled Design
NCT number | NCT03593135 |
Other study ID # | 1481 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 15, 2017 |
Est. completion date | November 14, 2017 |
Verified date | July 2018 |
Source | Sheikh Zayed Federal Postgraduate Medical Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: apple cider vinegar is natural traditional health beneficial nutraceutical used
for many aliments. Diabetes mellitus (DM) has been considered a globally major health problem
and posing health burden on families and health system. Diabetes is associated with life
style that leading to reduce physical activities and increased in obesity. For development of
diabetes the known mechanism are endocrine disorders which cause impaired insulin secretion,
hepatic glucose over production and insulin resistance.
Objective: The aim of current randomized controlled trial was to investigate the effect of
apple cider vinegar on glycemic control and biochemical parameters in type 2 diabetic
patients with poor glycaemic control.
Material & Methods: 110 type 2 diabetic patients according to inclusion criteria were
selected and divided into two groups. Interventional group was given 15 ml apple cider
vinegar in 200ml water during meal at night time for 3 months. Before and after HbA1C,
fasting lipid profile, fasting blood sugar, anthropometrics and dietary changes were assessed
and analyzed using IBM SPSS version 20 through paired sample T-test where needed.
Status | Completed |
Enrollment | 126 |
Est. completion date | November 14, 2017 |
Est. primary completion date | November 14, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Adult patients having uncontrolled type 2 diabetes with raised HbA1c levels. - Both gender. - Age ranging from 30-60 years. - All having body mass index between 20-30. - Non alcoholics. - Non smoker. - All were on standard medical therapy for diabetes (including Metformin + Sitagliptin group). Exclusion Criteria: - Patients suffering from known chronic renal disease. - History of cardiovascular diseases like stroke, ischemic heart disease. - Known allergy to vinegar. - intolerance to vinegar, reported by the patient or relative. - Any kind of acute infection were excluded from study. |
Country | Name | City | State |
---|---|---|---|
Pakistan | Shaikh Zayed Medical Complex | Lahore | Punjab |
Lead Sponsor | Collaborator |
---|---|
Sheikh Zayed Federal Postgraduate Medical Institute |
Pakistan,
Clarke P. Seat belts. Lancet. 1977 May 28;1(8022):1155. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HbA1c (Glycosylated Hemoglobin) | Before start of intervention and after intervention 5ml venous blood sample was taken for biochemical analysis of HbA1C (glycosylated hemoglobin) in sterilized tubes,commercial kits of Siemens for Dimmension RxL used and the HbA1C measuement is based on a turbidimetric inhibition immunoassay (TINIA) priniciple. | 3 months | |
Secondary | blood sugar fasting | Before start of intervention and after intervention 5ml venous blood sample was taken with 12 hours fasting for biochemical analysis of blood sugar fasting in sterilized dray tubes,commercial kits of Siemens for Dimmension XL and photometric methods for analysis was used. | 3 months | |
Secondary | fasting lipid profile | Before start of intervention and after intervention 5ml venous blood sample was taken with 12 hours fasting for biochemical analysis of fasting lipid profile commercial kits of Rodex for Dimmension Rxl and photometric methods for analysis were used. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |